CSS
SLDB icon

Cubist Systematic Strategies’s Solid Biosciences SLDB Stock Holding History

Cubist Systematic Strategies’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,613
Closed -$262K – 3461
2024
Q4 		$262K Buy
65,613
+54,288
+479% +$298K ﹤0.01% 2461
2024
Q3 		$78.9K Sell
11,325
-61,320
-84% -$497K ﹤0.01% 2722
2024
Q2 		$412K Buy
+72,645
New +$651K ﹤0.01% 2222
2022
Q1 		– Sell
-1,248
Closed -$33K – 3750
2021
Q4 		$33K Buy
+1,248
New +$38.1K ﹤0.01% 3352
2021
Q3 		– Sell
-4,546
Closed -$250K – 3154
2021
Q2 		$250K Buy
4,546
+946
+26% +$62.5K ﹤0.01% 2438
2021
Q1 		$299K Buy
3,600
+2,660
+283% +$294K ﹤0.01% 2254
2020
Q4 		$107K Buy
+940
New +$59.5K ﹤0.01% 2397
2019
Q3 		– Sell
-813
Closed -$70K – 2451
2019
Q2 		$70K Buy
+813
New +$88.7K ﹤0.01% 2281
2019
Q1 		– Sell
-542
Closed -$218K – 2402
2018
Q4 		$218K Buy
+542
New +$255K 0.01% 1481

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cubist Systematic Strategies's SLDB Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Solid Biosciences (SLDB) in Q1 2025, closing a stake of 65,613 shares — an estimated $262K sold.

Cubist Systematic Strategies first reported a position in SLDB in Q4 2018 and held it in 9 quarters. The position peaked at $412K in Q2 2024. 124 funds tracked by Wall St. Rank hold SLDB as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Solid Biosciences position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 65,613 Solid Biosciences shares in Q1 2025, an estimated $262K.
  • Cubist Systematic Strategies first reported a position in Solid Biosciences in Q4 2018 and held it in 9 quarters.
  • Cubist Systematic Strategies's Solid Biosciences position peaked at $412K in Q2 2024.
  • 124 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.